Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant

The nucleoprotein (NP) of influenza viruses is highly conserved and therefore has become one of the major targets of current universal influenza vaccine (UIV) studies. In this study, the recombinant nucleoprotein (NP) of the A/PR/8/34 (H1N1) influenza virus strain was expressed using an Escherichia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Vaccin Immunother
Hauptverfasser: Zheng, Mei, Liu, Fen, Shen, Yiqing, Wang, Shilei, Xu, Wenting, Fang, Fang, Sun, Bing, Xie, Zhenyuan, Chen, Ze
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2015
Schlagworte:
INFLUENZA/Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514371/
https://ncbi.nlm.nih.gov/pubmed/25607884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.995056
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge